miR-125a and miR-125b overexpression significantly decreased proliferation of ovarian cancer cells within 48 to 72 h of treatment (Figure 5A, 5B), as did the knockdown of EIF4EBP1 (Figure 5C). Here, EIF4EBP1 is linked to ovarian carcinoma.